Zenabis Archives

StaffNovember 1, 2022

The Daily Hit is a recap of cannabis business news for Nov. 1, 2022. ON THE SITE New York Regulators Roll Back Cannabis Testing Standards New York cannabis regulators on Tuesday took a major step in easing testing lab safety standards for the upcoming recreational marijuana market, apparently in response to industry pressure regarding contamination […]

Debra BorchardtNovember 1, 2022

Hexo is completely out of Zenabis.

Debra BorchardtJune 17, 2022

HEXO Corp. (NASDAQ: HEXO) acknowledged today that its wholly-owned subsidiary, Zenabis Global Inc. has filed a petition with the Superior Court of Québec for protection under the Companies’ Creditors Arrangement Act in order to restructure their business and financial affairs. CCAA is basically the Canadian version of bankruptcy. Hexo said that the CCAA petition is limited […]

Debra BorchardtApril 1, 2021

Zenabis Global Inc. (OTC: ZBISF) announced its financial results for the year and quarter ending December 31, 2020. Zenabis reported that net revenue for the quarter decreased by 16% sequentially from $19 million in the third quarter to $15 million in the fourth quarter. It was an improvement over 2019’s fourth-quarter revenue of $10.9 million. The […]

Debra BorchardtFebruary 17, 2021

HEXO Corp. (TSX: HEXO; NYSE: HEXO) is buying Zenabis Global Inc. (TSX: ZENA) in an all-stock deal valued at approximately $235 million. Zenabis had hinted that such a deal was in the making during its fight with Sundial. In January, the company had said it had started talks with another significant licensed cannabis producer, so […]

StaffJune 19, 2020

Columbia Care Columbia Care Inc. (OTCQX: CCHWF) said it expects to complete the second tranche of its previously announced $50.0 million financing with the offering of an aggregate principal amount of $15.7 million in 5.00% senior secured convertible notes due 2023. $12.8 million of escrowed funds are expected to close on or by June 22 […]

Debra BorchardtMay 19, 2020

Zenabis Global Inc. (OTC:ZBISF) reported rising revenue in Canadian dollars for the first quarter ending March 31, 2020. Zenabis‘s revenue rose 18% sequentially to $12.6 million and easily surpassing last year’s $4.1 million for the same time period. The net losses dropped dramatically to $1.5 million from the fourth quarter’s net loss of $98 million. […]

Debra BorchardtMarch 31, 2020

Under the cover of darkness Zenabis Global Inc. (TSX:ZENA) delivered its earnings in Canadian dollars. It was 1 am when Zenabis issued its press release reported that its 2019 net revenue was $66.5 million, while its net loss for the year was $127 million or $0.53 per share. The net revenue did increase 850% over 2018’s […]

Debra BorchardtFebruary 19, 2020

Zenabis Global Inc. (TSX: ZENA) announced details of its cannabis derivative product strategy and execution, including entering into an agreement with a Canadian beverage manufacturer to produce a range of cannabis-infused beverages. In December 2019, Zenabis signed a definitive agreement with HYTN Beverages Inc. (“HYTN“) to produce a range of cannabis-infused beverages at Zenabis Stellarton. […]

Debra BorchardtNovember 25, 2019

The Facilities Are Fully Funded On Oct. 9, 2019, The Green Organic Dutchman (OTC: TGOD) said in a press release that it was updating the market on credit financing. In the statement, it noted that “The Company may revise the construction schedule for its Ancaster and Valleyfield projects if it is unable to obtain sufficient […]

Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC

Functional Mushrooms Move Into Mainstream as Wellness Trend Grows

In other news

The Daily Hit: January 4, 2024

Connecticut Attorney General Tells Unlicensed Cannabis Events Company to Stop

Testing Concerns Lead to Quarantine for 70% of Mississippi MMJ Goods

Tag: Zenabis

The Daily Hit: November 1, 2022

Hexo Reports $1 Billion Loss for Fiscal Year 2022

Hexo Confirms Zenabis Financial Trouble

Zenabis Revenue Falls From Third Quarter

Zenabis Finds Savior In Hexo Acquisition

Money Moves: Columbia Care, Zenabis

Zenabis Reports Rising Revenue From Bulk Shipments In First Quarter

Zenabis Reports Losses Of $127 Million On Revenue Of $66 Million

Zenabis To Produce Sparkling Beverages

The Four Biggest Fibs In Cannabis For 2019

The Daily Hit - TEST TEST TEST

Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC

Functional Mushrooms Move Into Mainstream as Wellness Trend Grows

Get the latest cannabis news delivered right to your inbox

Get the latest cannabis news delivered right to your inbox